Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Major Depressive Disorder
IRCT20220127053839N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atorvastatin in major depressive disorder (MDD), sponsored by Mazandaran University of Medical Sciences. Started Mar 2022; status: completed.
02
Drugs
atorvastatin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20220127053839N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220127053839N1.